Spero Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2015 | $-53.11 | $-70.30 |
| FY2016 | $-95.87 | $-97.80 |
| FY2017 | $-17.82 | $-72.81 |
| FY2018 | $-2.60 | $-55.42 |
| FY2019 | $-3.35 | $-45.15 |
| FY2020 | $-3.52 | $-38.34 |
| FY2021 | $-2.91 | $-33.34 |
| FY2022 | $-1.23 | $-29.34 |
| FY2023 | $0.43 | $-26.03 |
| FY2024 | $-1.27 | $-23.56 |
| FY2025 | $0.15 | $-16.51 |